Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms × pembrolizumab × Clear all

Phase

Status

Sponsor Class

OTHER 83 INDUSTRY 49 NIH 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostate Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Oligometastatic Squamous Cell Carcinoma of the Head and Neck 1 Neoplasm, Residual 1 Mouth Neoplasms 1 Mesothelioma 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hodgkin Disease 1 Gallbladder Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 34 Docetaxel 26 Tamoxifen 23 Paclitaxel 22 Doxorubicin 21 Trastuzumab 19 Radiotherapy 16 Epirubicin 13 Letrozole 10 Fluorouracil 9 Capecitabine 8 Bevacizumab 8 Anastrozole 8 exemestane 7 Immunohistochemistry 7 Gene Expression Profiling 7 Filgrastim 7 Methotrexate 6 Lapatinib 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 palbociclib 5 Zoledronic Acid 5 Microarray Analysis 5 Absorptiometry, Photon 5 Vinorelbine 4 Surgical Procedures, Operative 4 Reverse Transcriptase Polymerase Chain Reaction 4 Psychiatric Rehabilitation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02129556 2019-02-15

PANACEA

ETOP IBCSG Partners Foundation

Phase 1/2 Completed

58 enrolled 16 charts

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡